AMTX vs WELL · rev $77.2M vs P/E 100, rev $10.84B
Aemetis Inc (AMTX) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
AMTX currently screens at market cap $158.3M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the AMTX and WELL stock pages for the full models.
Not investment advice.